Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Baxter
Merck
McKesson
Moodys

Last Updated: October 17, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR NEBIVOLOL HYDROCHLORIDE

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Nebivolol Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00125853 The Effect of Nebivolol on Insulin Sensitivity Completed Foundation for Circulatory Health N/A 2006-07-01 The purpose of this study is to conduct a randomised trial to compare the insulin sensitivity, 24 hour blood pressure profile, and tolerability of nebivolol plus a thiazide-like diuretic versus atenolol plus a thiazide-like diuretic.
NCT00125853 The Effect of Nebivolol on Insulin Sensitivity Completed Imperial College London N/A 2006-07-01 The purpose of this study is to conduct a randomised trial to compare the insulin sensitivity, 24 hour blood pressure profile, and tolerability of nebivolol plus a thiazide-like diuretic versus atenolol plus a thiazide-like diuretic.
NCT00142584 Evaluation of the Long-Term Safety and Tolerability of Metoprolol Versus Nebivolol in Patients With Hypertension Completed Mylan Bertek Pharmaceuticals Phase 3 2005-08-01 The purpose of this study is to evaluate long-term safety,tolerability and blood pressure effects of metoprolol versus nebivolol in patients with hypertension. These drugs may be given alone or in combination with other drugs that are commonly used in the treatment of hypertension
NCT00145210 Safety and Efficacy of Nebivolol in the Treatment of Hypertension in African Americans Completed Mylan Bertek Pharmaceuticals Phase 3 2005-04-01 The purpose of this study is to evaluate the effects of nebivolol on blood pressure and heart rate in African American patients with hypertension.
NCT00145236 Dosing Study of the Effects of Nebivolol on Blood Pressure in Black Patients With Mild to Moderate Hypertension Completed Mylan Bertek Pharmaceuticals Phase 3 2001-11-01 The purpose of this study was to determine if nebivolol is superior to placebo for the treatment of elevated blood pressure in Black patients with mild to moderate hypertension.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Nebivolol Hydrochloride

Condition Name

Condition Name for Nebivolol Hydrochloride
Intervention Trials
Hypertension 51
Heart Failure 5
Erectile Dysfunction 2
High Blood Pressure 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Nebivolol Hydrochloride
Intervention Trials
Hypertension 47
Heart Failure 7
Prehypertension 3
Erectile Dysfunction 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Nebivolol Hydrochloride

Trials by Country

Trials by Country for Nebivolol Hydrochloride
Location Trials
United States 304
Italy 3
Puerto Rico 3
Korea, Republic of 2
Greece 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Nebivolol Hydrochloride
Location Trials
Texas 16
Florida 16
California 13
Georgia 13
Tennessee 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Nebivolol Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Nebivolol Hydrochloride
Clinical Trial Phase Trials
Phase 4 40
Phase 3 15
Phase 2/Phase 3 2
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Nebivolol Hydrochloride
Clinical Trial Phase Trials
Completed 53
Recruiting 8
Unknown status 6
[disabled in preview] 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Nebivolol Hydrochloride

Sponsor Name

Sponsor Name for Nebivolol Hydrochloride
Sponsor Trials
Forest Laboratories 39
Mylan Bertek Pharmaceuticals 9
Emory University 3
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Nebivolol Hydrochloride
Sponsor Trials
Other 68
Industry 61
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Boehringer Ingelheim
Dow
Moodys
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.